Treatment of Listeria Monocytogenes Infection
The first-line treatment for Listeria monocytogenes infection is high-dose intravenous ampicillin or amoxicillin, often in combination with gentamicin for synergistic effect, especially in cases of invasive disease such as meningitis or septicemia. 1, 2
Recommended Treatment Regimens
- For invasive listeriosis (meningitis, endocarditis): 15-20 million units/day of IV penicillin G for 2-4 weeks depending on infection site 3
- For immunocompromised patients: Combination therapy with ampicillin/amoxicillin plus gentamicin is recommended for synergistic effect 2
- For penicillin-allergic patients: Trimethoprim-sulfamethoxazole (TMP-SMX) is the preferred alternative 1, 2
- Fluoroquinolones should be avoided, particularly during pregnancy 4
Treatment Considerations for Special Populations
Pregnant Women
- Prompt treatment is critical as Listeria infection during pregnancy can lead to miscarriage, stillbirth, and neonatal infection 5
- Safe antibiotics for pregnant women with listeriosis include ampicillin, cefotaxime, ceftriaxone, or TMP-SMX 1, 4
- Fluoroquinolones should be strictly avoided during pregnancy 4
Immunocompromised Patients
- Patients on immunosuppressive therapy (especially anti-TNF agents) are at higher risk for severe Listeria infections 1
- Immunosuppressive therapy should be temporarily withheld until resolution of active infection 1
- Higher doses and longer treatment durations may be necessary for immunocompromised patients 3
Clinical Presentation and Diagnosis
Listeriosis can present as:
Diagnosis is made by:
Prevention Strategies
- Prevention of Listeria infection consists of food hygiene and careful food choices 1
- High-risk individuals should avoid:
Common Pitfalls and Caveats
- Listeriosis can mimic other infections, leading to delayed diagnosis and treatment 6
- A high index of suspicion is needed for patients on immunosuppressive therapy who present with neurological symptoms 1
- Comprehensive investigation, including lumbar puncture, should be performed promptly when Listeria infection is suspected in high-risk individuals 1
- Between 17% and 33% of all cases of invasive Listeria disease occur among pregnant women, unborn fetuses, or newborn infants, representing a 13-17 fold increase compared with the general population 1
- Mortality remains high (20-30%) in invasive listeriosis despite appropriate antimicrobial therapy 2, 8